Stories about research and scientific development at Mount Sinai
Champions of Children’s Health
More than 700 attendees showed their support for children’s environmental health at The Mount Sinai Medical Center’s sixth annual Greening Our Children luncheon, held on Monday, May 20, at the Hyatt Regency Greenwich in Connecticut. Proceeds from the event—which...
A Transformational Gift for Children’s Health
Eric M. Mindich, a member of Mount Sinai’s Boards of Trustees, and his wife, Stacey Mindich, have provided a leadership gift to advance groundbreaking science to improve children’s health. In recognition of their generosity, Mount Sinai’s Child Health and Development...
Mount Sinai Streamlines its Research Administration Enterprise
The Icahn School of Medicine at Mount Sinai has begun rolling out a series of projects for investigators in basic, translational, and clinical research that will streamline the research administration structure and make it easier to initiate and submit protocols and...
New Discoveries in Head and Neck Cancers
Shutting down inflammation within the body, and then harnessing the immune system to recognize and destroy cancer cells, could provide the one-two punch needed to effectively treat head and neck cancers, according to researchers at Icahn School of Medicine at Mount...
First Generation Scholars
In 2008, a first-year medical student named Jennifer Ling developed a program called the First Generation College Application Essay Writing and Scholarship Program, under the sponsorship of Students for Equal Opportunity in Medicine (SEOM). There were six students in...
Baby Boomers Should Get Tested for Hepatitis C!
According to the CDC, all “Baby Boomers” should get tested for hepatitis C. This is based only on age and for this recommendation Baby Boomers are defined as those born between 1945 and 1965 Hepatitis C (HCV) is a viral infection of the liver that can lead to...
Leadership in Scientific Education
The Graduate School of Biomedical Sciences has been training many of our nation’s finest scientists for more than four decades and inspiring them to translate their discoveries into effective treatments for human diseases. Today, Mount Sinai is a leader in bringing...
Cancer Researcher Ramon E. Parsons, MD, PhD, Joins Mount Sinai
Ramon E. Parsons, MD, PhD, a highly acclaimed researcher in cancer genetics, has joined Icahn School of Medicine at Mount Sinai as the Ward-Coleman Chair in Cancer, and Chair of the Department of Oncological Sciences. Dr. Parsons succeeds Stuart Aaronson, MD, Jack and...
New Myelofibrosis Drug Holds Promise
In a phase I clinical trial, physicians at The Mount Sinai Medical Center have identified the first drug that appears to stop the progression of myelofibrosis, a life-threatening blood cancer. The investigators found that, at low-doses, panobinostat (LBH589)...